InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Glickman Mark A. Officer active across 4 companies, notably Aralez Pharmaceuticals Inc.. Cumulatively, 5 disclosures have been published. History available since 6 December 2022. The latest transaction was filed on 30 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Glickman Mark A is a declarant with 5 filings in total. In the 5 sampled recent filings, the transactions are attributions, with a date range from 2016-02-09 to 2025-07-01 and buy and sell amounts of EUR 0 each. The companies mentioned in these filings are MetaVia Inc., NeuroBo Pharmaceuticals, Inc., TherapeuticsMD, Inc. and Aralez Pharmaceuticals Inc., with the listed roles of Director, Co-Chief Executive Officer and Chief Commercial Officer.